Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology.
Gohlke-Bärwolf
C
C
Yvoir, Belgium; H. P. Krayenbühl, Zürich, Switzerland, M. Krzeminska-Pakula, Lodz, Poland; M. Samama, Paris, France.
Acar
J
J
Oakley
C
C
Butchart
E
E
Burckhart
D
D
Bodnar
E
E
Hall
R
R
Delahaye
J P
JP
Horstkotte
D
D
Krémer
R
R
D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006349:Heart Valve Diseases / Q000097:blood / Q000150:complications*; D006350:Heart Valve Prosthesis; D006801:Humans; D007231:Infant, Newborn; D011183:Postoperative Complications / Q000097:blood / Q000517:prevention & control*; D011247:Pregnancy; D012307:Risk Factors; D013923:Thromboembolism / Q000097:blood / Q000517:prevention & control*
D000925:Anticoagulants